This inventor holds 1 USPTO granted patent. Top assignee: Boehringer Ingelheim Gmbh. Active years: 1981.
Company Filing History:
Years Active: 1981
Title: Hanns Ihrig: Innovator in Antianginal Treatments
Introduction
Hanns Ihrig is a notable inventor based in Biberach, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antianginal treatments. His work has led to the creation of innovative compositions that aim to improve patient outcomes.
Latest Patents
Hanns Ihrig holds a patent for an antianginal treatment utilizing azepine derivatives. The patent describes pharmaceutical compositions containing a compound where R1 can be hydrogen, unsubstituted or hydroxyl-substituted alkyl of 1 to 4 carbon atoms, allyl, or various substituted benzyl groups. This innovative approach has the potential to enhance the effectiveness of antianginal therapies.
Career Highlights
Ihrig is associated with Boehringer Ingelheim GmbH, a leading global pharmaceutical company. His work there has focused on developing new therapeutic options for patients suffering from angina, showcasing his commitment to advancing medical science.
Collaborations
Throughout his career, Hanns Ihrig has collaborated with esteemed colleagues such as Walter Kobinger and Lothar Benedikter. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Hanns Ihrig's contributions to antianginal treatments exemplify the impact of dedicated inventors in the pharmaceutical industry. His innovative work continues to pave the way for advancements in patient care.